跳至主要内容
临床试验/PACTR202311776445720
PACTR202311776445720招募中Unknown

Medical Management of Second Trimester Missed Miscarriage using a combination of Mifepristine-misoprostol versus Misoprostol alone

Rabiatu Musa Ahmed0 个研究点目标入组 72 人开始时间: 2022年11月19日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
Female

入选标准

  • Patients diagnosed with a missed miscarriage by pelvic ultrasound scan in the second trimester of pregnancy
  • Patients who give informed consent to medical management of missed miscarriage in second trimester.

排除标准

  • Patients with known allergy to mifepristone or misoprostol
  • Patients with coagulation disorders
  • Patients with a previous Caesarean delivery/myomectomy
  • Life threatening bleeding,
  • Contraindications to mifepristone or misoprostol,
  • Patients who do not give consent
  • Patients who opt for alternative means of miscarriage management
  • Patients with multiple gestation

研究者

发起方
Rabiatu Musa Ahmed

相似试验